Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel

Neurobiol Dis. 2011 Jul;43(1):163-75. doi: 10.1016/j.nbd.2011.03.008. Epub 2011 Mar 13.

Abstract

Through the use of live confocal imaging, electron microscopy, and the novel cell biological platform of cultured Aplysia neurons we show that unfolding of the hallmark cell pathologies induced by mutant-human-tau (mt-human-tau) expression is rescued by 10 nM paclitaxel. At this concentration paclitaxel prevents mt-human-tau-induced swelling of axonal segments, translocation of tau and microtubules (MT) to submembrane domains, reduction in the number of MTs along the axon, reversal of the MT polar orientation, impaired organelle transport, accumulation of macro-autophagosomes and lysosomes, compromised neurite morphology and degeneration. Unexpectedly, higher paclitaxel concentrations (100 nM) do not prevent these events from occurring and in fact facilitate them. We conclude that antimitotic MT-stabilizing reagents have the potential to serve as drugs to prevent or slow down the unfolding of tauopathies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology*
  • Animals
  • Aplysia
  • Cells, Cultured
  • Humans
  • Mitosis / drug effects
  • Mitosis / genetics
  • Nerve Degeneration / drug therapy*
  • Nerve Degeneration / genetics
  • Nerve Degeneration / pathology*
  • Neurons / drug effects*
  • Neurons / pathology*
  • Neurons / ultrastructure
  • Paclitaxel / pharmacology*
  • Protein Unfolding / drug effects
  • Tauopathies / drug therapy
  • Tauopathies / genetics
  • Tauopathies / pathology
  • Transduction, Genetic / methods
  • Tubulin Modulators / pharmacology
  • tau Proteins / adverse effects
  • tau Proteins / antagonists & inhibitors
  • tau Proteins / genetics

Substances

  • Tubulin Modulators
  • tau Proteins
  • Paclitaxel